After a slow start to the month, the IPO market revved back to life with 13 IPOs coming to market this past week. SPAC activity picked up, with seven blank check IPOs raising $940 million. New filers continued to flood the IPO pipeline, with fourteen IPOs and...read more
Sera Prognostics, which develops diagnostic tests for pregnancy complications, raised $75 million by offering 4.7 million shares at $16, within the range of $15 to $17. Sera Prognostics uses its proprietary proteomics and bioinformatics platform to develop...read more
Updated Monday, 7/12. After a slow holiday week, 15 IPOs are scheduled to raise nearly $4 billion in the week ahead. A handful of SPACs should also price. Italian drug container supplier Stevanato Group (STVN) plans to raise $900...read more
Sera Prognostics, which develops diagnostic tests for pregnancy complications, announced terms for its IPO on Thursday. The Salt Lake City, UT-based company plans to raise $75 million by offering 4.7 million shares at a price range of $15 to $17. At the...read more
US IPO Weekly Recap: The summer IPO market heats up in a 13 IPO week
After a slow start to the month, the IPO market revved back to life with 13 IPOs coming to market this past week. SPAC activity picked up, with seven blank check IPOs raising $940 million. New filers continued to flood the IPO pipeline, with fourteen IPOs and...read more
Pregnancy diagnostics company Sera Prognostics prices IPO at $16 midpoint
Sera Prognostics, which develops diagnostic tests for pregnancy complications, raised $75 million by offering 4.7 million shares at $16, within the range of $15 to $17. Sera Prognostics uses its proprietary proteomics and bioinformatics platform to develop...read more
US IPO Week Ahead: Real estate, post-pandemic plays and more in a 15 IPO week
Updated Monday, 7/12. After a slow holiday week, 15 IPOs are scheduled to raise nearly $4 billion in the week ahead. A handful of SPACs should also price. Italian drug container supplier Stevanato Group (STVN) plans to raise $900...read more
Pregnancy diagnostics company Sera Prognostics sets terms for $75 million IPO
Sera Prognostics, which develops diagnostic tests for pregnancy complications, announced terms for its IPO on Thursday. The Salt Lake City, UT-based company plans to raise $75 million by offering 4.7 million shares at a price range of $15 to $17. At the...read more